Maybe try Cagrilintide with a GLP-1 if appetite is the main issue? See below
For the record I have NOT tried it. Tirz suppresses my appetite enough
Cagrilintide (aka Cagri) is a long-acting amylin analog developed for appetite suppression and weight loss, especially in combination with GLP-1 drugs like semaglutide or tirzepatide. Here’s the quick and dirty breakdown of how it works and why it’s gaining traction in the fat-loss pharmaco-toolbox:
⸻

What is Cagrilintide?
• It mimics amylin, a hormone co-secreted with insulin by pancreatic beta cells.
• Amylin plays a key role in satiety, gastric emptying, and glucagon suppression.
• Think of it as the “I’m full, stop eating” signal that GLP-1 doesn’t fully cover.
⸻

Mechanisms of Appetite Suppression
Cagrilintide acts through central and peripheral pathways:
1. Slows gastric emptying – You feel full longer.
2. Enhances satiety signaling – Works on the area postrema and hypothalamus.
3. Suppresses glucagon – Helps stabilize blood glucose and prevent hunger swings.
4. Amplifies GLP-1 action – Synergistic when paired with GLP-1 agonists like semaglutide or tirzepatide.
⸻

Why It’s a Big Deal
• Superior appetite control compared to GLP-1 alone
• Reduces food cravings, especially for hyperpalatable foods
• Delayed gastric emptying is more pronounced than GLP-1s
• In clinical trials (e.g., AMG 133 and SURMOUNT pipeline), it showed greater weight loss when combined with semaglutide
⸻

Data Highlights
• Cagrilintide + semaglutide = additive or even synergistic fat loss
• Weight loss in some studies: 15–20%+ total body weight over ~1 year
• May suppress food intake for longer periods than sema alone
⸻

Protocol (Experimental/Off-label Insight)
Note: Not FDA-approved yet as a standalone. Often sourced from research peptide suppliers.
• Dosing: ~0.3 mg up to 4.5 mg weekly (titrated slowly)
• Often co-dosed same day as GLP-1, or staggered based on side effects
• Injection: SubQ, similar to semaglutide
⸻

Side Effects (What to Expect)
• Nausea (especially if combined with GLP-1)
• Constipation or delayed bowel movements
• Possible hypoglycemia when combined with insulin or sulfonylureas
• Titration helps mitigate most GI issues
⸻
TL;DR
Cagrilintide is like semaglutide’s quiet but powerful wingman. It crushes hunger, slows digestion, and supercharges satiety—especially when stacked with GLP-1s. On its own? Solid. In a stack? Weaponized.
If you want a biochemical muzzle for your appetite, Cagri’s the muzzle. Just start low, go slow, and keep the barf bucket nearby the first week.